CoChat

Effect of cyclical intermittent hypoxia on Ad5CMVCre induced solitary lung cancer progression and spontaneous metastases in the KrasG12D+; p53fl/fl; myristolated p110fl/fl ROSA-gfp mouse

Open access

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Epidemiological data suggests that obstructive sleep apnea (OSA) is associated with increased cancer incidence and mortality. We investigate the effects of cyclical intermittent hypoxia (CIH), akin to the underlying pathophysiology of OSA, on lung cancer progression and metastatic profile in a mouse model. METHODS: Intrathoracic injection of Ad5CMVCre virus into a genetically engineered mouse (GEM) KrasG12D+/-; p53fl/fl; myristolated-p110αfl/fl-ROSA-gfp was utilized to induce a solitary lung cancer. Male mice were then exposed to either CIH or Sham for 40-41 days until harvest. To monitor malignant progression, serial micro CT scans with respiratory gating (no contrast) was performed. To detect spontaneous metastases in distant organs, H&E and immunohistochemistry were performed. RESULTS: Eighty-eight percent of injected Ad5CMVCre virus was recovered from left lung tissue, indicating reliable and accurate injections. Serial micro CT demonstrated that CIH increases primary lung tumor volume progression compared to Sham on days 33 (p = 0.004) and 40 (p<0.001) post-injection. In addition, CIH increases variability in tumor volume on day 19 (p<0.0001), day 26 (p<0.0001), day 33 (p = 0.025) and day 40 (p = 0.004). Finally, metastases are frequently detected in heart, mediastinal lymph nodes, and right lung using H&E and immunohistochemistry. CONCLUSIONS: Using a GEM mouse model of metastatic lung cancer, we report that male mice with solitary lung cancer have accelerated malignant progression and increased variability in tumor growth when exposed to cyclical intermittent hypoxia. Our results indicate that cyclical intermittent hypoxia is a pathogenic factor in non-small cell lung cancer that promotes the more rapid growth of developing tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0212930

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Validating intrathoracic injection technique. (A) A standard calibration curve was made using known quantities of Ad5CMVCre to then quantify unknown samples of Ad5CMVCre. Six different known concentrations of Ad5CMVCre were spiked into lung tissue to make the standard calibration curve: 3.12x105, 6.24x105, 1.56x106, 3.12x106, 1.56x107, and 3.12x107 pfu. (B) Amount of Ad5CMVCre (in pfu) measured in 14 mice that had their left lung injected with 3.12x107 pfu Ad5CMVCre virus. Measurements were made using the TaqMan real-time PCR assay. The bar plot shows the mean with standard error and overlaying dot plot shows measurements of individual animals (n = 14). pfu = plaque-forming unit, a standard measure of the number of particles capable of forming plaques per unit volume. (C-D) To characterize Ad5CMVCre activity in the left lung of KrasG12D+/-; p53fl/fl; myristolated-p110αfl/fl-ROSA-gfp mice, gfp immunohistochemistry was used to detect Cre-recombination effect within the left lung, 4 days after Ad5CMVCre injection. (C) A representative micrograph of no gfp/Cre-recombination in the left lung of a mouse that had no Ad5CMVCre virus injected serves as a negative control. (D.1) A representative micrograph of activation of gfp/Cre-recombination in the left lung of a mouse that underwent Ad5CMVCre virus injection. To validate that the virus did not enter the bloodstream to turn on other primary cancers, (D.2) is representative of no gfp/Cre-recombination activation in the right lung and (D.3) is representative of no gfp/Cre-recombination activation in the heart.
Fig 1 Validating intrathoracic injection technique. (A) A standard calibration curve was made using known quantities of Ad5CMVCre to then quantify unknown samples of Ad5CMVCre. Six different known concentrations of Ad5CMVCre were spiked into lung tissue to make the standard calibration curve: 3.12x105, 6.24x105, 1.56x106, 3.12x106, 1.56x107, and 3.12x107 pfu. (B) Amount of Ad5CMVCre (in pfu) measured in 14 mice that had their left lung injected with 3.12x107 pfu Ad5CMVCre virus. Measurements were made using the TaqMan real-time PCR assay. The bar plot shows the mean with standard error and overlaying dot plot shows measurements of individual animals (n = 14). pfu = plaque-forming unit, a standard measure of the number of particles capable of forming plaques per unit volume. (C-D) To characterize Ad5CMVCre activity in the left lung of KrasG12D+/-; p53fl/fl; myristolated-p110αfl/fl-ROSA-gfp mice, gfp immunohistochemistry was used to detect Cre-recombination effect within the left lung, 4 days after Ad5CMVCre injection. (C) A representative micrograph of no gfp/Cre-recombination in the left lung of a mouse that had no Ad5CMVCre virus injected serves as a negative control. (D.1) A representative micrograph of activation of gfp/Cre-recombination in the left lung of a mouse that underwent Ad5CMVCre virus injection. To validate that the virus did not enter the bloodstream to turn on other primary cancers, (D.2) is representative of no gfp/Cre-recombination activation in the right lung and (D.3) is representative of no gfp/Cre-recombination activation in the heart.CC0 · PubMed Central
Fig 2 Representative micro CT of lung tumor progression. (A) Representative single 2D coronal slice (largest length x width) of serial micro CT scans of one mouse exposed to cyclical intermittent hypoxia (upper panel) and one mouse exposed to room air (Sham) (lower panel) at 12, 19, 26, 33, and 40 days after Ad5CMVCre intrathoracic injection. (B) Using ITK snap, manual segmentation of the lung tumor, outlined in red, allows for precise 2D contouring of lung tumors in consecutive 100um coronal slices. C & D. ITK snap then automatically stitches all 2D segmented tumors and calculates a 3D tumor volume that is then used to compare CIH vs Sham tumor progression. A representative 3D tumor anterior (C) and posterior (D) visualization of a lung tumor from the same mouse in (B) is colored in red.
Fig 2 Representative micro CT of lung tumor progression. (A) Representative single 2D coronal slice (largest length x width) of serial micro CT scans of one mouse exposed to cyclical intermittent hypoxia (upper panel) and one mouse exposed to room air (Sham) (lower panel) at 12, 19, 26, 33, and 40 days after Ad5CMVCre intrathoracic injection. (B) Using ITK snap, manual segmentation of the lung tumor, outlined in red, allows for precise 2D contouring of lung tumors in consecutive 100um coronal slices. C & D. ITK snap then automatically stitches all 2D segmented tumors and calculates a 3D tumor volume that is then used to compare CIH vs Sham tumor progression. A representative 3D tumor anterior (C) and posterior (D) visualization of a lung tumor from the same mouse in (B) is colored in red.CC0 · PubMed Central
Fig 3 Representative H&E stain of left lung tumor of mouse exposed to cyclical intermittent hypoxia (A) compared to Sham (B). Primary tumor is outlined by red arrows [1.25X magnification].
Fig 3 Representative H&E stain of left lung tumor of mouse exposed to cyclical intermittent hypoxia (A) compared to Sham (B). Primary tumor is outlined by red arrows [1.25X magnification].CC0 · PubMed Central
Fig 4 Tumor volume measured by micro CT scans. Tumor volume and associated 95% confidence intervals estimated from linear mixed model analysis are shown. Data for individual mice are shown. We found a significantly faster increase in tumor volume in the CIH versus Sham groups (p = 0.0003) and significant differences between the two groups across all timepoints (overall p<0.0001). In pairwise comparisons at each individual timepoint, the CIH group had trending or significantly greater tumor volume at day 26 (p = 0.055), day 33 (p = 0.004) and day 40 (p<0.0001). Sample size is as follows: for CIH at Day 12 (n = 11), Day 19 (n = 11), Day 26 (n = 11), Day 33 (n = 11), Day 40 (n = 10); for Sham at Day 12 (n = 13), Day 19 (n = 13), Day 26 (n = 13), Day 33 (n = 13), Day 40 (n = 13).
Fig 4 Tumor volume measured by micro CT scans. Tumor volume and associated 95% confidence intervals estimated from linear mixed model analysis are shown. Data for individual mice are shown. We found a significantly faster increase in tumor volume in the CIH versus Sham groups (p = 0.0003) and significant differences between the two groups across all timepoints (overall p<0.0001). In pairwise comparisons at each individual timepoint, the CIH group had trending or significantly greater tumor volume at day 26 (p = 0.055), day 33 (p = 0.004) and day 40 (p<0.0001). Sample size is as follows: for CIH at Day 12 (n = 11), Day 19 (n = 11), Day 26 (n = 11), Day 33 (n = 11), Day 40 (n = 10); for Sham at Day 12 (n = 13), Day 19 (n = 13), Day 26 (n = 13), Day 33 (n = 13), Day 40 (n = 13).CC0 · PubMed Central
Fig 5 Variability in tumor volume as measured by micro CT scans. The measured tumor volume within the CIH and Sham groups in each time point is demonstrated. We found significantly greater variability in tumor volumes for the CIH group compared to Sham at day 19 (p<0.0001), day 26 (p<0.0001), day 33 (p = 0.025) and day 40 (p = 0.004).
Fig 5 Variability in tumor volume as measured by micro CT scans. The measured tumor volume within the CIH and Sham groups in each time point is demonstrated. We found significantly greater variability in tumor volumes for the CIH group compared to Sham at day 19 (p<0.0001), day 26 (p<0.0001), day 33 (p = 0.025) and day 40 (p = 0.004).CC0 · PubMed Central
Fig 6 Metastases visualized at harvest. (A) Metastases to right lung (black arrows) is visualized at harvest in addition to primary tumor (white arrows) in the left lung (site of Ad5CMVCre virus injection). (B) Metastases to mediastinal lymph nodes (black chevron), rib (yellow chevron) and sternum (white chevron) is visualized at harvest.
Fig 6 Metastases visualized at harvest. (A) Metastases to right lung (black arrows) is visualized at harvest in addition to primary tumor (white arrows) in the left lung (site of Ad5CMVCre virus injection). (B) Metastases to mediastinal lymph nodes (black chevron), rib (yellow chevron) and sternum (white chevron) is visualized at harvest.CC0 · PubMed Central
Fig 7 Metastases, histology. (A) H&E stain confirms primary tumor in left lung (red chevrons outline border of primary tumor) as well as metastases to right lung (black chevron-RL) and mediastinal lymph nodes (black chevron-MLN). Surfactant protein C (SPC) immunohistochemistry demonstrates metastases to the heart in a CIH mouse (B.1) and Sham mouse (B.3). We provide SPC immunohistochemistry to CIH lung (B.2) and Sham lung (B.4) for positive control. All micrographs taken at 40X, bar is 50 microns.
Fig 7 Metastases, histology. (A) H&E stain confirms primary tumor in left lung (red chevrons outline border of primary tumor) as well as metastases to right lung (black chevron-RL) and mediastinal lymph nodes (black chevron-MLN). Surfactant protein C (SPC) immunohistochemistry demonstrates metastases to the heart in a CIH mouse (B.1) and Sham mouse (B.3). We provide SPC immunohistochemistry to CIH lung (B.2) and Sham lung (B.4) for positive control. All micrographs taken at 40X, bar is 50 microns.CC0 · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 77 references

Research works printed but not linked: 1

  1. EL Jackson, 2001, Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras, Gene Dev, 15, 3243, 10.1101/gad.943001 · DOI · Paper page

Cited by

See all 23

Metadata

Authors
Guo, X., Liu, Y., Kim, J. L., Kim, E. Y., Kim, E. Q., Jansen, A., Li, K., Chan, M., Keenan, B. T., Conejo-Garcia, J., & Lim, D. C.
Affiliations
  • University of Pennsylvania (US)
  • Jilin University (CN)
  • Moffitt Cancer Center (US)
Corresponding author
Lim, Diane C.
Venue
PLOS ONE
Published
2019-02-27
Volume
14
Issue
2
Pages
e0212930
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2916780279
Cited by
23
References
77
Citations by year
2026: 2 · 2025: 3 · 2024: 6 · 2023: 2 · 2022: 5 · 2021: 2 · 2020: 3
FWCI
1.71
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, public-domain)
  • Europe PMC (PubMed Central) (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • VA VISN4 CPPF (9360-01656)
  • ASMF- Junior Faculty Research Award (154-JF-16)
  • National Cancer Institute (2R01CA124515)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
obstructive sleep apnea, lung cancer progression, spontaneous metastasis, KRAS G12D, p53, PI3K/Akt signaling, genetically engineered mouse models, tumor volume, non-small cell lung cancer
MeSH terms
Animals, Hypoxia, Solitary Pulmonary Nodule, Cytomegalovirus, Humans, Male, Mediastinum, Mice, Transgenic, Myocardium, Neoplasm Metastasis, Ribs, Tumor Suppressor Protein p53, Proto-Oncogene Proteins p21(ras), Disease Progression, Mice, X-Ray Microtomography, Class I Phosphatidylinositol 3-Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of cyclical intermittent hypoxia on Ad5CMVCre induced solitary lung cancer progression and spontaneous metastases in the KrasG12D+; p53fl/fl; myristolated p110fl/fl ROSA-gfp mouse. https://app.cochat.ai/papers/10.1371/journal.pone.0212930
The paper
Guo, X., Liu, Y., Kim, J. L., Kim, E. Y., Kim, E. Q., Jansen, A., Li, K., Chan, M., Keenan, B. T., Conejo-Garcia, J., & Lim, D. C. (2019). Effect of cyclical intermittent hypoxia on Ad5CMVCre induced solitary lung cancer progression and spontaneous metastases in the KrasG12D+; p53fl/fl; myristolated p110fl/fl ROSA-gfp mouse. PLOS ONE. https://doi.org/10.1371/journal.pone.0212930

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.